Back to mobile site

Sangamo Biosciences (SGMO) Tops Q4 EPS by 11c

February 28, 2017 7:02 AM EST

Sangamo Biosciences (NASDAQ: SGMO) reported Q4 EPS of ($0.14), $0.11 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $3.91 million.

For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings